(Q36924485)

17 August 2017

title

Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do. (English)

1 reference

17 August 2017

main subject

irritable bowel syndrome

1 reference

1

Mark Pimentel

1 reference

17 August 2017

Sheila Lezcano

2

1 reference

17 August 2017

language of work or name

1 reference

1 August 2007

1 reference

Current treatment options in gastroenterology

17 August 2017

published in

1 reference

17 August 2017

volume

10

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

328-337

1 reference

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11938-007-0076-1

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11938-007-0076-1

Dual publication of surgical abstracts is acceptable

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11938-007-0076-1

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

12 December 2020

The degree of breath methane production in IBS correlates with the severity of constipation

1 reference

12 December 2020

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

1 reference

12 December 2020

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial

1 reference

12 December 2020

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

1 reference

12 December 2020

Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study

1 reference

12 December 2020

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

12 December 2020

Postinfectious irritable bowel syndrome--a meta-analysis

1 reference

12 December 2020

Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention

1 reference

12 December 2020

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

1 reference

12 December 2020

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

1 reference

12 December 2020

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

12 December 2020

The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs

1 reference

12 December 2020

A migrating electric complex of canine small intestine

1 reference

12 December 2020

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

12 December 2020

The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity

1 reference

12 December 2020

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

1 reference

12 December 2020

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Malabsorption in intestinal scleroderma. Correction by antibiotics

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

12 December 2020

Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome

1 reference

12 December 2020

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

1 reference

12 December 2020

Functional bowel disorders and functional abdominal pain

1 reference

12 December 2020

Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin

1 reference

12 December 2020

Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis

1 reference

12 December 2020

The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine

1 reference

12 December 2020

Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction

1 reference

12 December 2020

Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

Evidence-based position statement on the management of irritable bowel syndrome in North America

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Intestinal pseudo-obstruction with bacterial overgrowth in the small intestine

1 reference

12 December 2020

Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls

1 reference

12 December 2020

Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex

1 reference

12 December 2020

The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects

1 reference

12 December 2020

Tolerance for rectosigmoid distention in irritable bowel syndrome

1 reference

12 December 2020

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

1 reference

12 December 2020

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

12 December 2020

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

1 reference

12 December 2020

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms after bacterial gastroenteritis. Study did not include a control group

1 reference

12 December 2020

Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study

1 reference

12 December 2020

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

1 reference

12 December 2020

The peristaltic reflex: An analysis of the nerve pathways and their pharmacology

1 reference

12 December 2020

Functional bowel disorders

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats

1 reference

12 December 2020

Breath methane associated with slow colonic transit time in children with chronic constipation

1 reference

12 December 2020

10.1007/S11938-007-0076-1

Identifiers

DOI

1 reference

release_42viiemwmvhvrn267atplx3xnu

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/42viiemwmvhvrn267atplx3xnu

24 November 2022

mapped directly with Wikidata item

1 reference